查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888590

全球多重检测试剂市场：市场规模、份额、趋势分析（按类型、应用、最终用途和地区划分）、细分市场预测（2025-2033 年）

Multiplex Testing Reagents Market Size, Share & Trend Analysis By Type (Biotin-based Reagents, Streptavidin-based Reagents), By Application (Autoimmune Disease Diagnostics, Oncology), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

多重检测试剂：市场概览

2024年全球多重检测试剂市场规模估计为14.2亿美元，预计2033年将达到41.5亿美元。

预计从 2025 年到 2033 年，其复合年增长率将达到 13.08%。多重检测试剂能够在一次检测中同时检测多种分析物，与传统的单一标靶检测相比，具有更高的效率和成本效益。

由于能够在短时间内提供全面的诊断数据，多重检测技术已被广泛应用于临床、科研和製药领域。此外，个人化医疗的需求日益增长，快速且准确地检测多种生物标记对于制定个人化的治疗方案至关重要，这也推动了市场成长。检测设计、自动化和检测平台的技术进步也提高了多重检测的可靠性和通量，使其成为实验室优化工作流程、最大限度减少样本量和营运成本的理想选择。

推动多重检测试剂成长的关键因素是全球慢性病和感染疾病的日益普及。心血管疾病、癌症、自体免疫免疫疾病和代谢症候群等慢性疾病通常涉及多种生物标记物，因此多重检测成为全面监测和诊断的有效工具。此外，包括病毒、细菌和新兴病原体在内的感染疾病在全球范围内日益加重，也促使人们需要能够同时检测多种病原体的高通量诊断解决方案。多重检测试剂使临床医生筛检合併感染并识别病原体谱，从而减少诊断延迟。这在公共卫生领域尤其重要，因为早期发现对于预防感染传播至关重要。因此，疾病盛行率的上升与多重检测试剂的日益普及直接相关，并推动了市场扩张。

技术创新是推动多重检测试剂市场成长的主要因素。先进的检测平台，例如以微珠为基础的流式细胞技术、微阵列和与次世代定序相容的试剂，正在提高多重检测的灵敏度、特异性和通量。自动化和与实验室资讯系统 (LIS) 的整合进一步简化了工作流程，使检查室能够在处理更大检体量的同时减少人为错误。新型试剂化学和标记技术提高了低表达生物标记检测的准确性，拓展了其临床和研究应用范围。此外，小型化和微流体技术实现了照护现场检测 (POC)，使患者能够更便捷地获得检查室级的分析。这些技术进步不仅提高了诊断准确性，还缩短了检测结果返回的时间并降低了成本，使得多重检测试剂对全球医院、诊断检查室和研究机构更具吸引力。

目录

第一章：多重检测试剂市场：分析方法与范围

2. 多重检测试剂市场：执行摘要

  • 市场概览
  • 按类型
  • 应用概述
  • 最终用途概述
  • 竞争格局概述

第三章：多重检测试剂市场：影响因素、趋势与范围

  • 市场区隔/范围
  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 精准诊断和个人化医疗的需求日益增长
    • 多重检测平台的技术进步
    • 加大药物发现与转化研究的研发投入
  • 市场限制因素分析
    • 多重检测所需的试剂和设备高成本
    • 复杂的检验和标准化挑战
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章：多重检测试剂市场：按类型分類的估算与趋势分析

  • 多重检测试剂市场：按类型分類的差异分析
  • 多重检测试剂市场：按类型分類的展望
  • 生物素基试剂
    • 生物素化抗体
    • 生物素标记探针/引物
    • 生物素标记的蛋白质/酶
  • 基于链霉亲和素的试剂
    • 链霉亲和素偶联的磁珠/微球
    • 链霉亲和素偶联酶和萤光染料
    • 重组链霉亲和素突变体经基因工程改造以提高稳定性
  • 其他的

第五章：多重检测试剂市场：按应用分類的估算与趋势分析

  • 多重检测试剂市场：按应用分類的差异分析
  • 多重检测试剂市场：按应用领域分類的展望
  • 自体免疫疾病诊断
  • 感染疾病诊断
  • 瘤
  • 过敏测试
  • 研究与转译医学
  • 药物发现与开发
  • 其他的

第六章：多重检测试剂市场：依最终用途分類的估算与趋势分析

  • 多重检测试剂市场：依最终用途分類的差异分析
  • 多重检测试剂市场：依最终用途分類的展望
  • 临床和诊断检查室
  • 医院
  • 製药和生物技术公司
  • CRO（委外研发机构）
  • 学术和研究机构

第七章 多重检测试剂市场：按地区分類的业务分析

  • 市场概览：按地区划分
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第八章 竞争情势

  • 公司分类
  • 策略规划
    • 新产品发布
    • 商业伙伴关係
    • 企业收购
    • 商业合作
    • 资金筹措
  • 主要企业市占率分析（2024 年）
  • 公司热力图分析
  • 公司简介
    • Luminex Corporation
    • Bio-Rad Laboratories, Inc.
    • Abcam plc.
    • Seegene Inc.
    • Merck KGaA
    • Illumina, Inc.
    • Promega Connections
    • QIAGEN NV
    • Thermo Fisher Scientific
    • PerkinElmer Inc.
    • Bio-Techne Corporation
    • BD
Product Code: GVR-4-68040-793-6

Multiplex Testing Reagents Market Summary

The global multiplex testing reagents market size was estimated at USD 1.42 billion in 2024 and is expected to reach USD 4.15 billion by 2033, growing at a CAGR of 13.08% from 2025 to 2033. Multiplex testing reagents enable the simultaneous detection of multiple analytes in a single test, offering higher efficiency and cost-effectiveness compared to conventional single-target assays.

Their ability to provide comprehensive diagnostic data in shorter timeframes has driven adoption across clinical, research, and pharmaceutical applications. The market's growth is further fueled by the increasing demand for personalized medicine, where rapid and precise detection of multiple biomarkers is critical for tailoring treatment strategies. Technological advancements in assay design, automation, and detection platforms have also enhanced the reliability and throughput of multiplex testing, making it an attractive choice for laboratories aiming to optimize workflow while minimizing sample volume and operational costs.

A primary factor driving the growth of multiplex testing reagents is the rising prevalence of chronic diseases and infectious conditions worldwide. Chronic illnesses such as cardiovascular disorders, cancer, autoimmune diseases, and metabolic syndromes often involve multiple biomarkers, making multiplex assays an efficient tool for comprehensive monitoring and diagnosis. In addition, the global burden of infectious diseases, including viral, bacterial, and emerging pathogens, has increased the need for high-throughput diagnostic solutions capable of detecting multiple pathogens simultaneously. Multiplex reagents allow clinicians to screen for co-infections and identify pathogen profiles in a single test, reducing diagnostic delays. This is particularly important in public health scenarios where early detection can prevent outbreaks. Consequently, growing disease prevalence directly correlates with increased adoption of multiplex testing reagents, thereby driving market expansion.

Technological innovation is a key driver of market growth for multiplex testing reagents. Advanced assay platforms, such as bead-based flow cytometry, microarrays, and next-generation sequencing-compatible reagents, have enhanced the sensitivity, specificity, and throughput of multiplex testing. Automation and integration with laboratory information systems have further streamlined workflows, allowing laboratories to process larger sample volumes with reduced human error. Novel reagent chemistries and labeling techniques have improved the detection of low-abundance biomarkers, expanding clinical and research applications. In addition, miniaturization and microfluidic technologies have enabled point-of-care multiplex testing, bringing laboratory-grade analysis closer to patients. These technological improvements not only improve diagnostic accuracy but also reduce turnaround time and costs, making multiplex testing reagents increasingly attractive for hospitals, diagnostic laboratories, and research institutions globally.

Global Multiplex Testing Reagents Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global multiplex testing reagents market report based on type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Biotin-based Reagents
    • Biotinylated Antibodies
    • Biotinylated Probes/primers
    • Biotin-tagged Proteins/enzymes
  • Streptavidin-based Reagents
    • Streptavidin-conjugated Beads/microspheres
    • Streptavidin-conjugated Enzymes & Fluorophores
    • Recombinant Streptavidin Variants (engineered for higher stability)
    • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Autoimmune Disease Diagnostics
  • Infectious Disease Diagnostics
  • Oncology
  • Allergy Testing
  • Research & Translational Medicine
  • Drug Discovery & Development
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical & Diagnostic Laboratories
  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Multiplex Testing Reagents Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type Segment
      • 1.1.1.2. Application Method
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Multiplex Testing Reagents Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type
  • 2.3. Application Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Multiplex Testing Reagents Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Growing demand for precision diagnostics and personalized medicine
    • 3.4.2. Technological advancements in multiplex assay platforms
    • 3.4.3. Rising r&d investments in drug discovery and translational research
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of multiplex assay reagents and equipment
    • 3.5.2. Complex validation and standardization challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Multiplex Testing Reagents Market: Type Estimates & Trend Analysis

  • 4.1. Multiplex Testing Reagents Market: Type Movement Analysis
  • 4.2. Multiplex Testing Reagents Market by Type Outlook (USD Million)
  • 4.3. Biotin-based Reagents
    • 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Biotinylated Antibodies
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Biotinylated Probes/primers
      • 4.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Biotin-tagged Proteins/enzymes
      • 4.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Streptavidin-based Reagents
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Streptavidin-conjugated Beads/microspheres
      • 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Streptavidin-conjugated Enzymes & Fluorophores
      • 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Recombinant Streptavidin Variants (engineered for higher stability)
      • 4.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Others
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Multiplex Testing Reagents Market: Application Method Estimates & Trend Analysis

  • 5.1. Multiplex Testing Reagents Market: Application Method Movement Analysis
  • 5.2. Multiplex Testing Reagents Market by Application Outlook (USD Million)
  • 5.3. Autoimmune Disease Diagnostics
    • 5.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Infectious Disease Diagnostics
    • 5.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Oncology
    • 5.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Allergy Testing
    • 5.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Research & Translational Medicine
    • 5.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Drug Discovery & Development
    • 5.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Multiplex Testing Reagents Market: End Use Estimates & Trend Analysis

  • 6.1. Multiplex Testing Reagents Market: End Use Movement Analysis
  • 6.2. Multiplex Testing Reagents Market by End Use Outlook (USD Million)
  • 6.3. Clinical & Diagnostic Laboratories
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Pharmaceutical & Biotechnology Companies
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Contract Research Organizations (CROs)
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Academic & Research Institutes
    • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Multiplex Testing Reagents Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Multiplex Testing Reagents Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. Middle East & Africa
    • 7.6.1. Middle East & Africa Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. Luminex Corporation
      • 8.5.1.1. Company Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Bio-Rad Laboratories, Inc.
      • 8.5.2.1. Company Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Abcam plc.
      • 8.5.3.1. Company Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Seegene Inc.
      • 8.5.4.1. Company Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Merck KGaA
      • 8.5.5.1. Company Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Illumina, Inc.
      • 8.5.6.1. Company Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Promega Connections
      • 8.5.7.1. Company Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. QIAGEN N.V.
      • 8.5.8.1. Company Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Thermo Fisher Scientific
      • 8.5.9.1. Company Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. PerkinElmer Inc.
      • 8.5.10.1. Company Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Bio-Techne Corporation
      • 8.5.11.1. Company Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. BD
      • 8.5.12.1. Company Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 4 North America multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 7 U.S. multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Canada multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 10 Canada multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 11 Canada multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Mexico multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 13 Mexico multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 14 Mexico multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 15 Europe multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
  • Table 16 Europe multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 17 Europe multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 18 Europe multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Germany multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 20 Germany multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 21 Germany multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 22 UK multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 23 UK multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 25 France multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 26 France multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 27 France multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Italy multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 29 Italy multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 30 Italy multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 31 Spain multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 32 Spain multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 33 Spain multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Denmark multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 35 Denmark multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 36 Denmark multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Sweden multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 38 Sweden multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 39 Sweden multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 40 Norway multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 41 Norway multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 42 Norway multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 47 China multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 48 China multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 49 China multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Japan multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 51 Japan multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 52 Japan multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 53 India multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 54 India multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 55 India multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 56 South Korea multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 57 South Korea multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 58 South Korea multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 59 Australia multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 60 Australia multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 61 Australia multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 62 Thailand multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 63 Thailand multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 64 Thailand multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Latin America multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
  • Table 66 Latin America multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 67 Latin America multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 68 Latin America multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Brazil multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 70 Brazil multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 71 Brazil multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 72 Argentina multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 73 Argentina multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 74 Argentina multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Middle East & Africa multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
  • Table 76 Middle East & Africa multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 77 Middle East & Africa multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 78 Middle East & Africa multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 79 South Africa multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 80 South Africa multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 81 South Africa multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 85 UAE multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 86 UAE multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 87 UAE multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
  • Table 88 Kuwait multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
  • Table 89 Kuwait multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
  • Table 90 Kuwait multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global Multiplex Testing Reagents Market - Key market driver analysis
  • Fig. 7 Global Multiplex Testing Reagents Market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global Multiplex Testing Reagents Market - Porter's analysis
  • Fig. 10 Global Multiplex Testing Reagents Market - PESTEL analysis
  • Fig. 11 Global Multiplex Testing Reagents Market Type outlook key takeaways
  • Fig. 12 Global Multiplex Testing Reagents Market: Type movement analysis
  • Fig. 13 Biotin-based Reagents Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Biotinylated Antibodies Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Biotinylated Probes/primers Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Biotin-tagged Proteins/enzymes Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Streptavidin-based Reagents Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 18 Streptavidin-conjugated Beads/microspheres Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Streptavidin-conjugated Enzymes & Fluorophores Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Recombinant Streptavidin Variants (engineered for higher stability) Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Others Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Global Multiplex Testing Reagents Market Application outlook key takeaways
  • Fig. 23 Global Multiplex Testing Reagents Market: Application movement analysis
  • Fig. 24 Autoimmune Disease Diagnostics Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Infectious Disease Diagnostics Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Oncology Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Allergy Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Research & Translational Medicine Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Drug Discovery & Development Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 30 Others Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Global Multiplex Testing Reagents Market End Use outlook key takeaways
  • Fig. 32 Global Multiplex Testing Reagents Market End Use movement analysis
  • Fig. 33 Clinical & Diagnostic Laboratories Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Hospitals Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Pharmaceutical & Biotechnology Companies Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 36 Contract Research Organizations (CROs)
  • Fig. 37 Academic & Research Institutes Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Global Multiplex Testing Reagents Market: Regional movement analysis
  • Fig. 40 North America Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 42 Canada Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 43 Mexico Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 45 UK Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 46 Germany Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 47 France Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 48 Spain Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 49 Italy Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 50 Denmark Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 51 Sweden Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 52 Norway Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 55 China Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 56 India Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 57 South Korea Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 58 Australia Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 59 Thailand Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 60 Latin America Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 61 Brazil Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 62 Argentina Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 63 MEA Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 64 South Africa Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 65 Saudi Arabia Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 66 UAE Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 67 Kuwait Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
  • Fig. 68 Strategy framework